glioblastoma
one
aggress
type
brain
cancer
median
surviv
time
approxim
one
year
character
rapid
prolifer
high
invas
glioma
resist
radiotherapi
chemotherapi
eventu
recur
oncolyt
virus
ov
genet
manipul
virus
destroy
cancer
cell
minim
damag
normal
healthi
tissu
virus
preferenti
replic
tumor
cell
lead
lytic
destruct
accompani
cell
lysi
viru
particl
burst
proceed
spread
infect
cancer
cell
world
first
ov
oncorin
ov
function
ident
approv
chines
state
food
drug
administr
regulatori
approv
ov
unit
state
europ
pend
result
random
larg
phase
iii
studi
despit
great
potenti
regulatori
approv
ov
clinic
use
china
ineffici
dispers
properti
within
tumor
ecm
recogn
major
barrier
antitumor
efficaci
tumor
ecm
play
pivot
role
inhibit
viru
spread
lead
limit
viral
replic
reduc
cytolyt
efficaci
major
ecm
compon
block
viral
dispers
neural
ecm
includ
hyaluron
acid
ha
proteoglycan
structur
compon
also
known
hinder
larg
therapeut
molecul
use
ecm
degrad
enzym
could
significantli
increas
efficaci
ov
treatment
enabl
viru
move
freeli
among
uninfect
tumor
cell
unlik
ecm
normal
tissu
tumor
ecm
continu
undergo
remodel
extens
synthesi
ecm
remodel
also
import
part
brain
tumor
angiogenesi
brain
ecm
contain
mainli
macromolecul
glycosaminoglycan
gag
proteoglycan
pg
smaller
fraction
fibrillari
glycoprotein
collagen
fibronectin
elastin
tumor
ecm
inhibit
penetr
antitumor
agent
lead
low
therapeut
efficaci
high
interstiti
fluid
pressur
inhibit
deliveri
agent
convect
tumor
interstiti
matrix
result
rather
passiv
diffus
major
mode
transport
macromolecul
tumor
penetr
macromolecul
igg
neg
correl
increas
collagen
content
use
collagenas
enzym
break
peptid
bond
collagen
shown
increas
diffus
macromolecul
igg
reduc
interstiti
fluid
pressur
enhanc
transvascular
transport
convect
proteas
hyaluronidasemedi
digest
ecm
enhanc
intratumor
penetr
mmpenhanc
oncolyt
relaxin
known
increas
antitumor
efficaci
viru
spread
relaxin
peptid
hormon
abl
reduc
synthesi
secret
interstiti
collagen
increas
level
metalloproteinas
mmp
oncolyt
adenoviru
express
relaxin
shown
promot
ov
dispers
tumor
ecm
howev
ecm
degrad
enzym
need
use
caution
sinc
intracran
use
degrad
enzym
caus
seriou
complic
exampl
hemorrhag
necrosi
brain
induc
collagenasemedi
ecm
disrupt
brain
proteas
associ
neurodegen
diseas
hyaluronidas
promot
optic
glioma
growth
astrocyt
reactiv
secret
membranebound
chondroitin
sulfat
proteoglycan
cspg
link
extracellular
hyaluronan
one
major
compon
ecm
brain
cspg
includ
versican
brevican
phosphacan
cspg
also
play
role
axon
growth
inhibitori
molecul
present
glial
scar
respons
part
regener
failur
scar
damag
cn
cn
tumor
increas
express
cspg
associ
tumor
growth
invas
angiogenesi
respons
diffusionlimit
properti
accumul
cspg
glioma
ecm
increas
tortuos
extracellular
space
interstiti
pressur
within
tumor
lead
poor
transport
larg
therapeut
agent
henc
enzymat
manipul
lower
cspg
level
would
way
improv
interstiti
transport
therapeut
agent
tumor
connect
ecm
macromolecul
consid
potenti
therapeut
target
adjuv
therapi
exampl
tumor
prolifer
dispers
inhibit
molecul
reduc
inhibit
block
antibodi
versican
interf
rna
phosphacan
cspg
also
degrad
lead
increas
hydraul
conduct
particl
diffus
solid
tumor
chondroitinas
abc
chaseabc
bacteri
enzym
remov
chondroitin
sulfat
glycosoamino
glycan
proteoglycan
without
deleteri
effect
vivo
studi
effect
neuron
regener
injuri
chaseabc
wide
use
enhanc
regener
injur
axon
tract
due
longlast
loosen
effect
ecm
scaffold
base
extens
posit
evid
preclin
model
chaseabc
recent
use
phase
iii
trial
treatment
patient
japan
effort
investig
use
bacteri
chondroitinas
enhanc
anticanc
therapi
dmitrieva
et
al
examin
effect
chaseabc
tumor
ecm
ov
spread
efficaci
experi
threedimension
glioma
spheroid
place
cultur
brain
slice
util
evalu
ov
spread
see
figur
replicationcondit
ov
express
chase
abc
ovchas
test
spread
efficaci
glioma
spheroid
glioma
xenograft
util
compar
antitumor
efficaci
ovchas
hsvq
control
pb
dmitrieva
et
al
found
ov
spread
glioma
spheroid
grown
brain
slice
significantli
enhanc
chaseabc
treatment
cell
migrat
invas
enhanc
ov
chase
treatment
togeth
result
suggest
degrad
ecm
ov
express
bacteri
chaseabc
key
factor
enhanc
ov
spread
anti
tumor
efficaci
shown
viru
spread
effici
spheroid
compar
controltr
spheroid
treat
chase
see
figur
kim
et
al
recent
develop
mathemat
model
invas
glioma
cell
tumor
spheroid
model
shown
capabl
reproduc
migrat
pattern
glioma
cell
vitro
experi
exhibit
particular
dispers
branch
cell
model
includ
mmp
activ
glucos
level
well
chemotaxi
haptotaxi
cellcel
adhes
forc
rapid
migrat
cell
caus
primarili
chemotaxi
forc
includ
glucos
level
sever
mathemat
model
brain
tumor
base
reactiondiffus
process
cellular
automata
transit
migrat
prolifer
use
kinet
diffus
model
intracellular
signal
pathway
gener
review
mathemat
model
tumor
growth
found
paper
develop
mathemat
model
base
schemat
diagram
figur
model
consist
coupl
system
partial
differenti
equat
involv
follow
variabl
shown
model
simul
spheric
glioma
qualit
agreement
experiment
result
common
practic
inject
viru
serval
differ
locat
within
tumor
mathemat
model
use
determin
prefer
locat
inject
materi
method
section
present
mathemat
model
result
section
simul
model
also
perform
sever
experi
propos
hypothes
paramet
estim
nondimension
model
numer
scheme
dimensionless
govern
equat
given
text
order
describ
time
evolut
densiti
differ
type
tumor
cell
uninfect
infect
dead
cell
take
account
cell
prolifer
tumor
cell
viru
infect
tumor
cell
follow
clearanc
process
passiv
movement
due
veloc
field
gener
tumor
growth
section
deriv
equat
equat
taken
model
friedman
et
al
veloc
prolifer
rate
uninfect
tumor
cell
infect
rate
infect
cell
lysi
rate
remov
rate
dead
cell
note
treatment
chaseabc
affect
equat
also
note
friedman
et
al
includ
effect
immun
system
immun
suppress
treatment
efficaci
ov
inject
present
paper
ignor
aspect
treatment
concentr
efficaci
deriv
chaseabc
treatment
secret
membranebound
chondroitin
sulfat
proteoglycan
cspg
describ
section
link
extracellular
hyaluronan
form
major
compon
ecm
brain
found
cspg
detect
glioma
cell
line
tumor
sampl
interfer
ov
spread
glioma
spheroid
abil
chondroitinas
abc
degrad
tumor
chondroitin
sulfat
proteoglycan
cspg
key
regul
factor
paper
hypothes
chaseabcmedi
digest
glioma
csgag
degrad
glioma
ecm
open
space
virus
diffus
faster
conserv
mass
cspg
concentr
give
flux
mobil
cspg
productiondeath
rate
cspg
convect
fluid
veloc
cspg
degrad
rate
given
describ
degrad
ecm
cspg
chondroitinas
abc
chaseabc
degrad
key
ecm
compon
cspg
assum
ecm
degrad
rate
proport
ecm
concentr
chase
concentr
degrad
rate
ecm
compon
cspg
summari
follow
govern
equat
cspg
concentr
equat
describ
time
evolut
cspg
densiti
chaseabcassist
degrad
cspg
passiv
movement
veloc
section
describ
movement
replicationdecay
process
viru
particl
within
complex
ecm
structur
cspg
microenviron
treatment
chaseabc
improv
viral
spread
assum
viru
spread
cspg
concentrationdepend
manner
duplic
undergo
apoptosi
conserv
mass
densiti
free
viru
particl
get
flux
mobil
birthdeath
rate
contribut
flux
flux
random
motil
free
virus
random
motil
depend
ecm
cspg
concentr
quantifi
viru
particl
outsid
infect
cell
freeli
move
around
less
dens
ecm
cspg
use
follow
phenomenolog
form
diffus
coeffici
pb
refer
case
inhibit
paramet
scale
factor
averag
local
densiti
ecm
concentr
local
neighborhood
ie
ball
disc
center
sens
radiu
volum
use
convent
outsid
tumor
give
assum
free
viru
particl
replic
replic
rate
presenc
infect
cell
lysi
death
rate
within
grow
tumor
clearanc
rate
virus
indic
characterist
function
domain
summari
follow
govern
equat
viru
densiti
next
deriv
time
evolut
chaseabc
concentr
respons
inject
secret
ecm
degrad
natur
decay
system
conserv
mass
concentr
chaseabc
get
flux
productiondecay
rate
chaseabc
contribut
flux
flux
diffus
process
diffus
coeffici
chaseabc
chaseabc
appli
far
away
field
degrad
key
ecm
compon
cspg
chaseabc
may
secret
infect
tumor
cell
viru
directli
appli
field
surround
grow
tumor
addit
inject
viru
take
account
natur
decay
molecul
set
function
describ
product
chondroitinas
depend
viru
infect
tumor
cell
possibl
factor
tumor
ecm
degrad
paramet
decay
rate
summari
govern
equat
chaseabc
follow
glioma
cell
destabil
normal
cellmatrix
structur
overexpress
gener
alter
neural
ecm
molecul
creat
disorgan
ecm
structur
promot
tumorcel
movement
prolifer
assum
prolifer
uninfect
tumor
cell
secret
tumor
ecm
materi
undergo
remodel
conserv
mass
get
secret
rate
ecm
materi
uninfect
tumor
cell
hilltyp
function
expon
hilltyp
function
paramet
maximum
capac
tumor
ecm
materi
govern
equat
coupl
follow
boundari
condit
outer
normal
vector
repres
free
boundari
paramet
refer
valu
given
tabl
first
compar
simul
result
experiment
data
experi
variou
human
glioma
cell
line
vero
cell
use
vitro
vivo
expriment
ovchas
oncolyt
bacteri
chaseabc
driven
promot
within
backbon
rhsvq
control
vitro
studi
order
see
spread
rhsvq
ovchas
glioma
spheroid
brain
slice
spheroid
infect
pfu
plaqu
form
unit
rhsvq
ovchas
infect
area
case
chase
chase
calcul
visual
quantif
infect
cell
appear
ovencod
gfp
time
vivo
studi
glioma
cell
implant
stereotact
posit
mm
later
bregma
depth
mm
anim
studi
anim
inocul
control
pb
viru
absenc
presenc
chaseabc
ten
day
tumor
cell
implant
intratumor
inject
hbss
indic
ov
perform
mice
bear
subcutan
tumor
initi
averag
volum
seventytwo
hour
viral
infect
amount
infecti
viral
particl
infect
area
quantifi
standard
method
figur
show
spatial
profil
uninfect
cell
infect
cell
dead
cell
viru
cspg
ecm
without
chase
treatment
without
chase
treatment
cspg
ecm
degrad
inhibit
figur
viru
spread
figur
limit
due
thick
ecm
compon
figur
show
local
viru
annulu
subdomain
infect
tumor
cell
dead
cell
local
peripheri
spheroid
due
inhibit
viru
spread
toward
center
spheroid
larg
portion
uninfect
tumor
cell
center
tumor
spheroid
hand
chase
treatment
promot
cspg
ecm
degrad
decomposit
figur
led
fast
effect
spread
viru
figur
infect
tumor
cell
near
spheroid
center
figur
one
also
observ
signific
reduct
uninfect
tumor
cell
densiti
figur
widespread
distribut
dead
tumor
cell
center
tumor
spheroid
figur
order
compar
comput
result
experiment
data
calcul
rel
infect
area
use
densiti
distribut
infect
tumor
cell
ie
use
infect
area
rel
total
area
glioma
spheroid
figur
show
rel
infect
area
black
without
ovchas
treatment
result
good
qualit
agreement
experiment
data
shown
figur
experi
simul
paper
demonstr
ovchas
treatment
improv
infect
viru
within
tumor
thu
decreas
burden
cancer
mass
microenviron
play
signific
role
regul
spread
treatment
efficaci
mani
type
cancer
includ
glioblastoma
chase
diffus
clearli
affect
tumor
microenviron
may
depend
mani
factor
composit
ecm
materi
vivo
system
figur
investig
effect
diffus
chase
viru
spread
rel
infect
area
increas
diffus
chase
increas
almost
tumor
cell
center
tumor
mass
infect
diffus
larger
control
case
hand
diffus
chase
decreas
viru
spread
sever
impair
exampl
infect
area
decreas
cell
peripheri
tumor
mass
infect
diffus
coeffici
chase
smaller
respect
impli
viru
spread
would
significantli
less
effect
tumor
locat
harsh
microenviron
ecm
compon
may
dens
pack
quickli
remodel
figur
show
viru
spread
combin
differ
diffus
coeffici
left
right
half
squar
domain
second
column
figur
pattern
infect
area
differ
combin
show
viru
spread
significantli
inhibit
area
low
diffus
diffus
chase
fix
left
half
domain
decreas
right
half
domain
tumor
cell
left
side
infect
mani
cell
near
center
tumor
mass
right
hand
side
infect
exampl
figur
base
valu
diffus
assign
left
half
smaller
valu
diffus
chase
assign
right
half
differ
diffus
lead
differ
pattern
viru
infect
left
right
half
domain
viru
infect
complet
throughout
left
half
tumor
cell
peripheri
spheroid
infect
right
half
domain
similar
pattern
observ
case
smaller
valu
right
figur
left
right
diffus
decreas
left
well
smaller
diffus
fix
right
infect
area
left
also
decreas
figur
well
figur
show
rel
infect
area
left
right
whole
domain
respect
four
case
figur
simul
result
figur
implic
efficaci
viru
spread
brain
chase
compon
inject
site
near
tumor
sinc
brain
tissu
includ
white
gray
matter
heterogen
natur
muir
et
al
abl
induc
secret
bacteri
chondroitinas
abc
mammalian
cell
modifi
nglycosyl
site
section
assum
infect
tumor
cell
secret
enzym
sinc
viru
use
cell
bodi
creat
enzym
insid
infect
cell
section
use
model
test
result
treatment
tumor
vivo
genet
engin
viru
secret
ecm
degrad
enzym
infect
cell
instead
inject
enzym
act
passiv
outsid
grow
spheroid
order
take
account
effect
secret
enzym
viru
infect
cell
set
equat
secret
rate
enzym
infect
cell
figur
show
profil
infect
tumor
cell
time
respons
variou
secret
rate
enzym
infect
cell
increas
indirect
secret
enzym
infect
cell
effect
promot
penetr
enzym
toward
tumor
center
degrad
ecm
compon
increas
infect
area
increas
exampl
tumor
cell
center
tumor
mass
infect
control
case
almost
tumor
cell
infect
even
tumor
center
next
consid
situat
viru
inject
take
place
differ
locat
figur
show
efficaci
redistribut
inject
ov
treatment
withwithout
chaseabc
rel
control
case
first
inject
total
ov
center
grow
glioma
withwithout
treatment
chase
inocul
remain
ov
peripheri
tumor
along
chase
treatment
control
case
amount
total
viru
inject
outsid
tumor
profil
infect
cell
control
case
case
without
chase
b
case
chase
c
shown
figur
viru
penetr
begin
peripheri
spheroid
stop
middleway
toward
center
final
time
control
case
figur
viral
infect
center
spheroid
spread
outward
aggress
case
viral
inject
center
figur
case
chase
treatment
inject
site
center
spheroid
figur
viral
infect
even
aggress
almost
tumor
cell
infect
final
time
figur
show
time
cours
total
rel
area
case
control
black
solid
figur
without
chase
blue
dot
figur
chase
red
dot
figur
inject
strategi
differ
locat
red
blue
improv
tumor
infect
compar
control
black
solid
treatment
chase
tumor
center
red
dot
lead
even
faster
viral
spread
figur
show
time
cours
rel
area
outer
ring
solid
inner
region
dot
case
without
chase
blue
figur
chase
red
figur
infect
area
outer
ring
case
withwithout
chase
treatment
blue
solid
red
solid
case
chase
treatment
red
dot
center
tumor
spheroid
lead
faster
spread
viru
compar
case
without
chase
blue
dot
inject
amount
viru
limit
due
safeti
concern
patient
increas
pressur
insid
brain
therefor
given
mri
imag
patient
brain
would
like
optim
efficaci
treatment
limit
number
viru
per
total
inject
care
choos
inject
site
simul
result
figur
show
improv
efficaci
viral
inject
center
tumor
peripheri
somewhat
support
recent
clinic
data
report
markert
et
al
inde
markert
et
al
investig
efficaci
ov
treatment
six
human
patient
two
inject
ov
first
inocul
pfu
center
tumor
mass
follow
surgic
resect
tumor
mass
remain
viru
inject
brain
tissu
near
boundari
resect
tumor
area
studi
viru
inject
tumor
tissu
cathet
left
place
tumor
resect
en
bloc
day
later
tissu
care
divid
three
section
distal
slice
proxim
proxim
refer
evalu
hsv
polymeras
dna
tissu
show
decreas
two
log
distal
proxim
tissu
four
six
patient
high
invas
glioma
cell
major
challeng
treatment
glioma
due
regrowth
tumor
convent
treatment
option
surgeri
chemo
radiotherapi
innov
therapeut
approach
target
invas
cell
necessari
order
improv
clinic
outcom
test
hypothes
efficaci
possibl
viral
therapi
erad
invas
glioma
cell
shed
main
tumor
core
purpos
assum
chaseabc
deliv
inject
differ
site
number
inject
site
inject
strength
simplic
assum
initi
configur
spheric
tumor
brain
tissu
invas
cell
random
locat
outsid
tumor
core
figur
inject
site
assum
locat
peripheri
spheric
tumor
figur
show
densiti
infect
tumor
cell
inject
chaseabc
differ
site
strength
site
figur
chaseabc
inject
near
north
east
ne
corner
result
virusinfect
area
ie
virusinfect
tumor
cell
ne
area
elsewher
hand
sinc
extracellular
viru
move
freeli
south
west
sw
corner
chaseabc
inject
viru
local
result
higher
concentr
infect
tumor
cell
narrow
strip
figur
show
strateg
inject
increas
number
chaseabc
number
infect
cell
increas
insid
tumor
also
among
invas
cell
note
howev
littl
improv
occur
inject
four
site
chaseabc
four
site
manag
diffus
quit
effect
entir
region
hour
furthermor
effect
chaseabc
remov
cspg
reach
satur
level
concentr
chaseabc
increas
infin
see
equat
conclud
tumor
figur
necessari
inject
chaseabc
four
strateg
chosen
site
larger
tumor
tumor
invas
cell
distribut
may
requir
addit
inject
site
rel
infect
area
invas
white
core
gray
total
glioma
cell
seven
case
shown
figur
number
inject
site
increas
infect
popul
invas
prolifer
tumor
cell
insid
core
increas
overal
model
predict
high
improv
efficaci
treatment
increas
white
bar
figur
howev
efficaci
treatment
infect
infiltr
glioma
cell
significantli
improv
increas
due
satur
phenomenon
mention
figur
show
rel
infect
area
infiltr
prolif
tumor
cell
variou
number
inject
site
inject
strength
efficaci
increas
increas
fix
increas
fix
howev
satur
effect
signific
increas
total
infect
area
increas
beyond
certain
limit
sinc
mani
inject
high
concentr
chaseabc
may
harm
normal
cell
model
suggest
choic
small
number
strateg
locat
site
eg
four
limit
concentr
chaseabc
optim
strategi
would
effect
erad
tumor
cell
visibl
core
tumor
also
isol
cluster
long
cluster
invas
cell
far
main
tumor
bulk
viru
could
also
transport
brain
tumor
vascular
rout
test
efficaci
chaseabc
kill
infiltr
cell
tumor
bulk
viru
suppli
intraven
inject
differ
site
thu
follow
viru
suppli
via
intraven
inject
number
blood
site
viru
transport
strength
concentr
virus
invas
tumor
cell
initi
distribut
random
locat
outsid
tumor
bulk
lower
panel
figur
absenc
chaseabc
viral
infect
effect
due
limit
viru
spread
invas
cell
prolifer
cell
main
tumor
bulk
virus
suppli
one
figur
five
figur
blood
vessel
site
infect
rate
infiltr
cell
increas
increas
figur
figur
howev
signific
improv
overal
penetr
main
tumor
bulk
due
lack
chaseabc
hand
signific
improv
infect
bulk
tumor
chaseabc
inject
four
site
figur
upper
panel
figur
show
initi
distribut
virus
figur
higher
viral
infect
also
observ
upper
part
domain
presenc
chaseabc
due
locat
viru
inject
site
thu
presenc
blood
vessel
close
invas
glioma
cell
bulk
tumor
natur
increas
efficaci
kill
infiltr
tumor
cell
viral
infect
figur
figur
previou
test
larger
number
blood
site
sourc
viral
inject
significantli
improv
efficaci
viral
spread
infect
invas
cell
bulk
tumor
shown
larg
number
virus
may
harm
normal
cell
exist
limit
viru
inject
especi
case
intraven
inject
control
much
virus
transport
rather
limit
due
differ
microenviron
tumor
resid
brain
entri
even
small
biolog
agent
brain
tissu
usual
complex
organ
bloodbrain
barrier
bbb
despit
success
transport
viru
via
blood
rout
viral
infect
glioma
deliveri
virus
may
depend
mani
factor
biochem
condit
blood
vessel
tissu
composit
geometri
therefor
given
blood
distribut
patient
one
use
optim
patientspecif
inject
strategi
minim
side
effect
ie
without
kill
normal
healthi
brain
cell
order
erad
invas
cell
tumor
bulk
experiment
result
report
obtain
case
one
primari
tumor
howev
glioma
cell
highli
invas
like
infiltr
brain
tissu
form
multifoc
satellit
lesion
time
diagnosi
recent
univari
analysi
imag
featur
patient
gbm
pope
et
al
found
multifocalitysatellit
lesion
addit
noncontrastenhanc
tumor
edema
statist
signific
prognost
indic
therefor
interest
determin
outcom
appli
viral
therapi
case
primari
secondari
tumor
present
particularli
challeng
case
size
one
secondari
tumor
increasingli
small
repres
small
satellit
lesion
two
tumor
close
togeth
far
apart
section
consid
two
situat
first
investig
effect
secondari
tumor
size
viru
infect
primari
secondari
tumor
absenc
presenc
chaseabc
figur
c
show
initi
distribut
uninfect
tumor
cell
primari
tumor
ellipsoid
shape
spheric
secondari
tumor
well
invas
cell
outsid
tumor
radiu
secondari
tumor
rel
larg
figur
small
figur
virus
inject
five
site
outsid
primari
secondari
tumor
figur
absenc
chase
chaseabc
much
differ
rel
infect
rate
primari
secondari
tumor
larg
figur
small
figur
size
secondari
tumor
fact
rel
infect
area
chang
much
variou
radii
secondari
tumor
primari
left
panel
white
bar
figur
secondari
right
panel
white
bar
figur
tumor
chaseabc
case
presenc
chaseabc
chaseabc
signific
improv
rel
chaseabc
case
infect
rate
primari
left
panel
black
bar
figur
secondari
right
panel
black
bar
figur
tumor
fix
secondari
tumor
size
increas
rel
infect
area
secondari
tumor
decreas
infect
rate
primari
tumor
stay
almost
constant
exampl
much
differ
infect
area
primari
tumor
final
time
larg
figur
small
figur
secondari
tumor
larg
portion
larger
secondari
tumor
infect
upper
right
corner
figur
area
smaller
secondari
tumor
infect
upper
right
corner
figur
experi
conclud
chase
treatment
rel
infect
area
increas
size
secondari
tumor
decreas
due
effici
spread
chase
throughout
rel
smaller
satellit
follow
aggress
effect
degrad
cspg
thu
result
much
less
physic
resist
viru
spread
second
test
investig
effect
distanc
primari
secondari
tumor
viru
infect
tumor
presenc
chaseabc
chaseabc
figur
c
show
initi
distribut
uninfect
tumor
cell
primari
tumor
ellipsoid
shape
spheric
secondari
tumor
well
invas
cell
outsid
tumor
distanc
primari
secondari
tumor
rel
larg
figur
small
figur
distanc
two
tumor
defin
distanc
center
point
tumor
ie
center
point
primari
secondari
tumor
respect
virus
inject
five
site
outsid
primari
secondari
tumor
figur
initi
profil
chaseabc
shown
figur
order
see
effect
chasedriven
enhanc
ecm
degrad
efficaci
viru
spread
tumor
two
differ
ecm
degrad
rate
control
normal
case
high
degrad
rate
secondari
tumor
consid
rate
primari
tumor
fix
control
paramet
model
figur
show
rel
infect
area
primari
secondari
tumor
variou
case
rel
infect
area
primari
secondari
tumor
increas
distanc
tumor
decreas
white
bar
figur
ecmdegrad
strength
secondari
tumor
increas
rel
infect
area
secondari
tumor
significantli
increas
regardless
distanc
two
tumor
right
panel
figur
howev
model
predict
viru
infect
primari
tumor
respons
larger
depend
nonlinear
fashion
left
panel
figur
enhanc
strength
ecmdegrad
secondari
tumor
slightli
decreas
rel
infect
area
primari
tumor
rel
larger
fix
promot
viru
spread
primari
tumor
close
secondari
tumor
rel
spread
chase
toward
primari
tumor
reduc
due
increas
degrad
secondari
tumor
follow
increas
spread
speed
chaseabc
toward
secondari
tumor
secondari
tumor
close
primari
tumor
high
viral
activ
secondari
tumor
may
induc
fast
viral
spread
neighbor
primari
tumor
lead
increas
viral
infect
primari
tumor
site
exampl
one
see
broad
infect
area
secondari
tumor
bridgelik
spread
virus
primari
secondari
tumor
tumor
close
figur
limit
spread
virus
observ
remot
locat
primari
tumor
figur
invas
cell
suscept
viru
infect
due
free
access
virus
infiltr
cell
gap
two
tumor
also
contribut
larger
infect
area
primari
tumor
acceler
gener
avail
virus
neighbor
region
close
primari
tumor
act
bridg
viru
transport
two
tumor
control
case
remot
close
satellit
shown
figur
respect
experi
see
chase
treatment
rel
infect
area
increas
distanc
satellit
primari
tumor
decreas
due
advantag
larger
viru
popul
near
primari
lesion
activ
viral
infect
henc
heavi
viral
duplic
outer
rim
primari
tumor
combin
two
experi
follow
rel
infect
area
rel
larg
secondari
tumor
small
close
primari
tumor
suggest
chase
may
perhap
consid
anti
metastat
enhanc
viral
therapi
genet
manipul
oncolyt
virus
show
great
potenti
destroy
cancer
cell
quick
replic
abil
minim
damag
normal
healthi
cell
despit
great
potenti
popular
china
us
europ
ineffici
ov
spread
entir
tumor
ecm
recogn
major
challeng
antitumor
efficaci
glioma
system
metastasi
rare
glioma
recur
local
less
resect
area
make
glioma
good
target
viru
therapi
accumul
cspg
glioma
ecm
associ
tumor
growthinvas
angiogenesi
increas
tortuos
extracellular
space
interstiti
pressur
within
tumor
result
block
transport
larg
therapeut
agent
tumor
prolifer
dispers
inhibit
ecm
macromolecul
reduc
dmitrieva
et
al
found
ov
spread
significantli
enhanc
ov
chase
treatment
make
chaseabc
one
import
therapeut
molecul
improv
interstiti
transport
therapeut
agent
tumor
studi
chase
express
interfer
viral
cytotox
viru
penetr
local
microenviron
may
depend
mani
factor
ecm
composit
deposit
collagen
fibrinogen
highli
permeabl
angiogen
vessel
constant
remodel
ecm
paper
model
phenomena
chaseassist
viru
spread
use
system
partial
differenti
equat
model
variabl
includ
tumor
cell
infect
uninfect
viru
dead
tumor
cell
ov
chondroitinas
ecm
compon
model
simul
qualit
agreement
experiment
result
dmitrieva
et
al
common
practic
inject
viru
sever
differ
locat
within
outsid
tumor
mass
mathemat
model
use
suggest
testabl
hypothes
prefer
locat
inject
absenc
chase
viral
spread
limit
inject
oncolyt
viru
cell
peripheri
spheroid
infect
leav
bulk
tumor
cell
uninfect
center
tumor
mass
hand
viral
penetr
toward
center
tumor
spheroid
improv
assist
chondroitinas
chase
much
larger
portion
tumor
cell
infect
near
center
tumor
spheroid
improv
due
abil
chase
degrad
thick
network
ecm
allow
viru
enter
easili
neighbor
site
viral
penetr
improv
smarter
viru
use
ie
viru
equip
ecm
degrad
enzym
infect
cell
effect
test
model
improv
efficaci
illustr
model
simul
figur
therefor
develop
smart
viru
arm
bacteri
chondroitinas
abc
power
ecm
degrad
enzym
may
provid
pivot
way
promot
viru
spread
within
tumor
increas
enzym
activ
thu
kill
tumor
cell
howev
note
use
degrad
enzym
may
caus
seriou
complic
hemorrhag
necrosi
brain
neurodegen
diseas
optic
glioma
growth
treatment
failur
glioblastoma
partial
attribut
cellular
heterogen
local
microenviron
also
found
microenviron
play
signific
role
viral
spread
demonstr
figur
implic
brain
tissu
variabl
diffus
coeffici
model
predict
viru
spread
quit
select
given
microenviron
impos
locationspecif
deliveri
viru
need
order
widen
infect
area
improv
efficaci
viru
treatment
infiltr
glioma
cell
creat
major
challeng
glioma
treatment
due
invis
standard
medic
devic
mri
cell
may
infiltr
narrow
intercellular
space
normal
cell
brain
tissu
deform
cell
bodi
nucleu
effect
use
myosin
ii
motor
therefor
import
develop
effici
deliveri
method
target
kill
dispers
tumor
cell
orthotop
glioma
model
rodent
brain
system
applic
intraven
vesicular
stomat
viru
vsv
may
effect
select
target
infect
remot
satellit
glioma
cell
cluster
well
tumor
bulk
test
efficaci
viru
therapi
erad
cell
addit
kill
tumor
cell
main
tumor
mass
biochem
biophys
constraint
optim
viru
therapi
chaseabc
treatment
would
also
effect
kill
invas
cell
long
stay
within
local
area
studi
found
inject
chaseabc
addit
inject
viru
effect
infect
kill
tumor
bulk
also
erad
infiltr
glioma
cell
even
presenc
low
densiti
blood
vessel
howev
may
effect
kill
migratori
glioma
cell
far
field
even
optim
strategi
addit
entri
even
small
biolog
agent
brain
tissu
usual
complex
organ
bloodbrain
barrier
bbb
ad
obstacl
viral
therapi
replic
therapeut
virus
abl
dissemin
part
tumor
viral
therapi
may
affect
local
area
near
blood
vessel
instanc
histolog
analysi
transduc
human
glioma
show
low
transduct
effici
retroviru
lacz
marker
gene
adenovir
lacz
marker
gene
region
tumor
neighbor
area
show
much
lower
effici
studi
indic
multipl
inject
need
infect
fulli
tumor
bulk
wall
tumor
caviti
improv
virus
shown
target
kill
cell
differ
region
insid
tumor
via
vessel
leakag
ie
viru
seed
multipl
site
studi
predict
improv
intraven
viral
deliveri
appropri
level
chaseabc
use
optim
way
virus
also
depend
specif
genet
defect
ra
myc
oncogen
activ
cell
cycl
statu
statu
hypox
environ
therefor
optim
patientspecif
strategi
would
necessari
order
get
better
clinic
outcom
without
caus
catastroph
result
silico
experi
found
size
tumor
satellit
distanc
primari
tumor
secondari
one
may
determin
efficaci
viral
therapi
chase
treatment
rel
infect
area
increas
size
secondari
tumor
decreas
effect
degrad
cspg
reduct
physic
resist
viral
spread
ii
rel
infect
area
increas
distanc
satellit
primari
tumor
decreas
advantag
rel
larg
viru
popul
near
primari
lesion
activ
viral
infect
henc
heavi
viral
duplic
outer
rim
primari
tumor
current
model
take
account
mani
factor
cell
migrat
angiogenesi
stromal
cell
within
tumor
constant
remodel
ecm
blood
flow
immun
system
control
growth
factor
epiderm
growth
factor
egf
fibroblast
growth
factor
fgf
may
play
signific
role
regul
efficaci
oncolyt
viru
therapi
fact
growth
factor
use
tag
associ
molecul
target
cancer
cell
oncolyt
viru
exampl
verheij
et
al
show
infect
malign
human
glioblastoma
cell
result
releas
progeni
viru
effici
elimin
cancer
cell
vitro
mani
research
group
studi
strategi
target
polymerco
adenoviru
egfr
temporalspati
dynam
growth
factor
fluctuat
affect
glioma
cell
invasionprolifer
efficaci
viral
therapi
larg
unknown
also
despit
advantag
oncolyt
viru
carrier
gene
therapi
clinic
applic
limit
due
practic
safeti
issu
immun
respons
tropism
viru
rather
system
administr
necessari
also
might
get
better
insight
consid
free
interstiti
bound
viru
instead
one
popul
viru
howev
mathemat
model
develop
herein
first
step
toward
incorpor
factor
hope
address
futur
work
final
note
approach
hybrid
model
use
describ
detail
mechan
effect
viru
penetr
cell
biomechan
control
duplic
viru
within
cell
intracellular
signal
within
cell
also
clear
effect
viru
therapi
would
work
small
group
invis
migratori
cell
spread
brain
tissu
free
surgeri
due
low
densiti
eventu
recur
individu
cell
migrat
might
depend
mani
factor
chemotaxi
haptotaxi
cellcel
adhes
microenvironment
factor
